Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Receivables (2016 - 2025)

Healthstream (HSTM) has disclosed Receivables for 16 consecutive years, with $39.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 10.41% to $39.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.0 million, a 10.41% increase, with the full-year FY2025 number at $39.0 million, up 10.41% from a year prior.
  • Receivables was $39.0 million for Q4 2025 at Healthstream, up from $33.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $47.3 million in Q1 2023 to a low of $30.7 million in Q3 2021.
  • A 5-year average of $36.8 million and a median of $35.7 million in 2024 define the central range for Receivables.
  • Peak YoY movement for Receivables: dropped 24.25% in 2021, then rose 22.31% in 2022.
  • Healthstream's Receivables stood at $34.9 million in 2021, then rose by 22.31% to $42.7 million in 2022, then dropped by 9.98% to $38.4 million in 2023, then decreased by 8.13% to $35.3 million in 2024, then grew by 10.41% to $39.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Receivables are $39.0 million (Q4 2025), $33.7 million (Q3 2025), and $31.5 million (Q2 2025).